Cargando…

Evidence of Local Concentration of α-Particles from (211)At-Labeled Antibodies in Liver Metastasis Tissue

We investigated the local concentration of α-particles from (211)At-labeled trastuzumab antibodies against human epidermal growth factor receptor type 2 antigens in liver metastasis tissue of mice. Methods: Mice carrying metastatic cancer in their liver were injected with (211)At-agent. After 12 h,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kodaira, Satoshi, Morokoshi, Yukie, Li, Huizi Keiko, Konishi, Teruaki, Kurano, Mieko, Hasegawa, Sumitaka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Society of Nuclear Medicine 2019
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6448461/ https://www.ncbi.nlm.nih.gov/pubmed/30291193 http://dx.doi.org/10.2967/jnumed.118.216853

Ejemplares similares

Validating α-particle emission from (211)At-labeled antibodies in single cells for cancer radioimmunotherapy using CR-39 plastic nuclear track detectors
por: Kodaira, Satoshi, et al.
Publicado: (2017)

α‐particle therapy for synovial sarcoma in the mouse using an astatine‐211‐labeled antibody against frizzled homolog 10
por: Li, Huizi Keiko, et al.
Publicado: (2018)

Locoregional therapy with α‐emitting trastuzumab against peritoneal metastasis of human epidermal growth factor receptor 2‐positive gastric cancer in mice
por: Li, Huizi Keiko, et al.
Publicado: (2017)

Contribution to dose in healthy tissue from secondary target fragments in therapeutic proton, He and C beams measured with CR-39 plastic nuclear track detectors
por: Kodaira, Satoshi, et al.
Publicado: (2019)

Estimation of biological effect of Cu-64 radiopharmaceuticals with Geant4-DNA simulation
por: Kusumoto, Tamon, et al.
Publicado: (2022)

The Paradoxical Behavior of microRNA-211 in Melanomas and Other Human Cancers
por: Ray, Animesh, et al.
Publicado: (2021)

Stabilization of an (211)At-Labeled Antibody with Sodium Ascorbate
por: Manabe, Shino, et al.
Publicado: (2021)

Significance of PD-L1 expression in carbon-ion radiotherapy for uterine cervical adeno/adenosquamous carcinoma
por: Iijima, Moito, et al.
Publicado: (2019)

Cytotoxicity of alpha-particle-emitting astatine-211-labelled antibody in tumour spheroids: no effect of hyperthermia.
por: Hauck, M. L., et al.
Publicado: (1998)

Astatine-211-Labeled Gold Nanoparticles for Targeted Alpha-Particle Therapy via Intravenous Injection
por: Huang, Xuhao, et al.
Publicado: (2022)

Significant changes in yields of 7-hydroxy-coumarin-3-carboxylic acid produced under FLASH radiotherapy conditions
por: Kusumoto, Tamon, et al.
Publicado: (2020)

Preclinical Development of [(211)At]meta- astatobenzylguanidine ([(211)At]MABG) as an Alpha Particle Radiopharmaceutical Therapy for Neuroblastoma
por: Batra, Vandana, et al.
Publicado: (2022)

Gold Nanostars: A Novel Platform for Developing (211)At-Labeled Agents for Targeted Alpha-Particle Therapy
por: Liu, Yang, et al.
Publicado: (2021)

Intratumour injection of immunoglobulins labelled with the alpha-particle emitter 211At: analyses of tumour retention, microdistribution and growth delay.
por: Larsen, R. H., et al.
Publicado: (1998)

Scaling parameter of the lethal effect of mammalian cells based on radiation-induced OH radicals: effectiveness of direct action in radiation therapy
por: Kusumoto, Tamon, et al.
Publicado: (2020)

Phase Ib study of durvalumab (MEDI4736) in combination with carbon-ion radiotherapy and weekly cisplatin for patients with locally advanced cervical cancer (DECISION study): study protocol for a prospective open-label single-arm study
por: Okonogi, Noriyuki, et al.
Publicado: (2022)

TMEM211 Promotes Tumor Progression and Metastasis in Colon Cancer
por: Chang, Yung-Fu, et al.
Publicado: (2023)

LINC01315 Impairs microRNA-211-Dependent DLG3 Downregulation to Inhibit the Development of Oral Squamous Cell Carcinoma
por: Chen, Fu-Bo, et al.
Publicado: (2020)

Intratumoral administration of astatine-211-labeled gold nanoparticle for alpha therapy
por: Kato, Hiroki, et al.
Publicado: (2021)

Space Radiation Research Unit, International Open Laboratory in NIRS
por: Uchihori, Yukio, et al.
Publicado: (2014)

Deciphering the Dichotomous Effects of PGC-1α on Tumorigenesis and Metastasis
por: Gravel, Simon-Pierre
Publicado: (2018)

PS211. Fear conditioning induced by interpersonal conflicts in patients with dysthymic disorder
por: Tada, Mitsuhiro, et al.
Publicado: (2016)

ZKSCAN5 Activates VEGFC Expression by Recruiting SETD7 to Promote the Lymphangiogenesis, Tumour Growth, and Metastasis of Breast Cancer
por: Li, Jingtong, et al.
Publicado: (2022)

Downregulation of miR-211-5p Promotes Carboplatin Resistance in Human Retinoblastoma Y79 Cells by Affecting the GDNF–LIF Interaction
por: Ke, Ning, et al.
Publicado: (2022)

Properties of $^{211}_{85}$At$_{126}$ as observed in the decay of $^{211}$Rn
por: Astner, G
Publicado: (1972)

DNA strand break induction of aqueous plasmid DNA exposed to 30 MeV protons at ultra-high dose rate
por: Ohsawa, Daisuke, et al.
Publicado: (2021)

Radioimmunotherapy with an (211)At‐labeled anti–tissue factor antibody protected by sodium ascorbate
por: Takashima, Hiroki, et al.
Publicado: (2021)

Immuno-PET and Targeted α-Therapy Using Anti–Glypican-1 Antibody Labeled with (89)Zr or (211)At: A Theranostic Approach for Pancreatic Ductal Adenocarcinoma
por: Watabe, Tadashi, et al.
Publicado: (2023)

Prognostic Factor Analysis and Nomogram Construction of Primary Retroperitoneal Liposarcoma: A Review of 10 Years of Treatment Experience in a Single Asian Cohort of 211 Cases
por: Zhuang, Aobo, et al.
Publicado: (2022)

Case Report: Pathological Complete Response in a Lung Metastasis of Phyllodes Tumor Patient Following Treatment Containing Peptide Neoantigen Nano-Vaccine
por: Sha, Huizi, et al.
Publicado: (2022)

Targeted α-therapy using astatine ((211)At)-labeled PSMA1, 5, and 6: a preclinical evaluation as a novel compound
por: Watabe, Tadashi, et al.
Publicado: (2022)

Tumor Targeting of (211)At-Labeled Antibody under Sodium Ascorbate Protection against Radiolysis
por: Takashima, Hiroki, et al.
Publicado: (2022)

Human dosimetry of free (211)At and meta-[(211)At]astatobenzylguanidine ((211)At-MABG) estimated using preclinical biodistribution from normal mice
por: Ukon, Naoyuki, et al.
Publicado: (2020)

Protection from contamination by (211)At, an enigmatic but promising alpha-particle-emitting radionuclide
por: Ohnuki, Kazunobu, et al.
Publicado: (2022)

(211)At-labeled immunoconjugate via a one-pot three-component double click strategy: practical access to α-emission cancer radiotherapeutics
por: Fujiki, Katsumasa, et al.
Publicado: (2018)

In vivo evaluation of integrin αvβ6-targeting peptide in NSCLC and brain metastasis
por: Fan, Di, et al.
Publicado: (2023)

SUN-211 Male Pseudohermaphroditism Due to 5α-Reductase-2 Deficiency
por: Selman-Geara, Antonio, et al.
Publicado: (2019)

α‐Emitting cancer therapy using (211)At‐AAMT targeting LAT1
por: Kaneda‐Nakashima, Kazuko, et al.
Publicado: (2021)

Analysis of the therapeutic gain in the treatment of human osteosarcoma microcolonies in vitro with 211At-labelled monoclonal antibody.
por: Larsen, R. H., et al.
Publicado: (1994)

Evaluation of therapeutic efficacy of (211)At-labeled farletuzumab in an intraperitoneal mouse model of disseminated ovarian cancer
por: Palm, Stig, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_85k3hn4a2750l6sjpbu3j1elme